Literature DB >> 16088946

Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.

Lu Gan1, Xiang-Liang Yang, Qiong Liu, Hui-Bi Xu.   

Abstract

Thioredoxin reductase (TrxR) in conjunction with thioredoxin (Trx) is a ubiquitous intracellular oxidoreductase system with antioxidant and redox regulatory roles. In some human tumors, the thioredoxin system is found overexpressed. We have used an antisense approach to investigate whether inhibition of TrxR overexpression can suppress the growth of human hepatocellular carcinoma SMMC-7721 cells. TrxR cDNA fragment was inserted in the antisense direction into pcDNA3.1/myc-His and SMMC-7721 cells were stably transfected with the plasmid construct. The results showed that TrxR antisense RNA could significantly reduce TrxR mRNA level and activity, and suppress the growth of SMMC-7721 cells. Cell-cycle analysis showed G2/M phase arrest in SMMC-7721 cells transfected with TrxR antisense plasmid. TrxR antisense RNA could significantly increase p53 mRNA level and decrease Bcl-2 mRNA level by reverse transcriptase-polymerase chain reaction (RT-PCR). Furthermore a significant decrease in human telomerase reverse transcriptase (hTERT) mRNA level was found in SMMC-7721 cells transfected with TrxR antisense plasmid. Flow cytometry and telomere fluorescence in situ hybridization (Flow FISH) showed that TrxR antisense RNA could significantly reduce the telomere fluorescence in SMMC-7721 cells. The results suggested that TrxR antisene RNA inhibited the growth of SMMC-7721 cells through an accumulation of cell cycle at G2/M phase, an increase in p53 mRNA level and a reduction in telomere fluorescence and Bcl-2, hTERT mRNA levels. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088946     DOI: 10.1002/jcb.20585

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  16 in total

Review 1.  Caveolin-1, cellular senescence and age-related diseases.

Authors:  Huafei Zou; Elena Stoppani; Daniela Volonte; Ferruccio Galbiati
Journal:  Mech Ageing Dev       Date:  2011-11-12       Impact factor: 5.432

Review 2.  Paradoxical Roles of Antioxidant Enzymes: Basic Mechanisms and Health Implications.

Authors:  Xin Gen Lei; Jian-Hong Zhu; Wen-Hsing Cheng; Yongping Bao; Ye-Shih Ho; Amit R Reddi; Arne Holmgren; Elias S J Arnér
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

3.  Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase.

Authors:  Garth Powis; Peter Wipf; Stephen M Lynch; Anne Birmingham; D Lynn Kirkpatrick
Journal:  Mol Cancer Ther       Date:  2006-03       Impact factor: 6.261

4.  Thioredoxin Reductase 1 Expression and Castration-recurrent Growth of Prostate Cancer.

Authors:  Swaroop S Singh; Yun Li; Oscar Harris Ford; Carol S Wrzosek; Diana C Mehedint; Mark A Titus; James L Mohler
Journal:  Transl Oncol       Date:  2008-09       Impact factor: 4.243

5.  Inhibition of thioredoxin reductase 1 by caveolin 1 promotes stress-induced premature senescence.

Authors:  Daniela Volonte; Ferruccio Galbiati
Journal:  EMBO Rep       Date:  2009-10-09       Impact factor: 8.807

Review 6.  Selenoproteins in Tumorigenesis and Cancer Progression.

Authors:  Sarah P Short; Christopher S Williams
Journal:  Adv Cancer Res       Date:  2017       Impact factor: 6.242

7.  The yin and yang of nrf2-regulated selenoproteins in carcinogenesis.

Authors:  Regina Brigelius-Flohé; Mike Müller; Doris Lippmann; Anna Patricia Kipp
Journal:  Int J Cell Biol       Date:  2012-05-08

8.  Thioredoxin reductase: a novel, independent prognostic marker in patients with hepatocellular carcinoma.

Authors:  Chunyan Li; Yan Peng; Binglang Mao; Kun Qian
Journal:  Oncotarget       Date:  2015-07-10

9.  Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells.

Authors:  Karin Anestål; Stefanie Prast-Nielsen; Narimantas Cenas; Elias S J Arnér
Journal:  PLoS One       Date:  2008-04-02       Impact factor: 3.240

10.  Gene expression changes for antioxidants pathways in the mouse cochlea: relations to age-related hearing deficits.

Authors:  Sherif F Tadros; Mary D'Souza; Xiaoxia Zhu; Robert D Frisina
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.